AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2021

Mar 3, 2021

29831_dirs_2021-03-02_f2c27d8c-9ee1-4174-bc97-62fd966d240f.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-27

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-27	Common Stock	F	23841.0000	$33.4900	Disposed	137727.0000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1759.0000	Indirect

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on February 26, 2021.